Griffin J F, Mackintosh C G, Buchan G S
Dept of Microbiology, University of Otago, Dunedin, New Zealand.
Trends Microbiol. 1995 Nov;3(11):418-24. doi: 10.1016/s0966-842x(00)88994-5.
While the etiology of tuberculosis is well understood, the nature of the protective immune response to the causative mycobacteria has remained a mystery. There is an urgent need to define protective immunity critically, and to develop alternative animal models to evaluate the efficacy of new-generation vaccines against tuberculosis in a cost-effective way.
虽然结核病的病因已为人熟知,但针对致病分枝杆菌的保护性免疫反应的本质仍是个谜。迫切需要严格界定保护性免疫,并开发替代动物模型,以经济有效的方式评估新一代抗结核疫苗的疗效。